ArticlePharmaceuticals (Basel, Switzerland)2023

Preliminary Evidence of Efficacy, Safety, and Treatment Satisfaction with Tirbanibulin 1% Ointment: A Clinical Perspective on Actinic Keratoses.

Elena Campione et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.